Literature DB >> 19229972

Prolonged QTc interval in children and young adults with sickle cell disease at steady state.

Robert I Liem1, Luciana T Young, Alexis A Thompson.   

Abstract

BACKGROUND: Prolongation of the QTc interval may be more common than previously believed among individuals with sickle cell disease (SCD). The clinical associations and natural history of QTc prolongation remain unclear in this population. Our objectives were to determine the prevalence of prolonged QTc and evaluate its relationship to clinical factors in children and young adults with SCD. PROCEDURES: We analyzed data from subjects 10 to 25 years old with SCD enrolled in our pulmonary hypertension screening protocol. Screening included echocardiography (ECHO), 12-lead electrocardiogram (ECG) and laboratory testing at steady state. QTc interval >440 msec was considered prolonged.
RESULTS: ECG data from 76 subjects (57% male, mean age 14.2 +/- 3 years old, range 10-24) were analyzed. We observed prolonged QTc in 29/76 (38%) subjects. Despite evidence of left ventricular hypertrophy (LVH) in 50/76 (66%) subjects, the frequency of LVH was not significantly different in subjects with and without QTc prolongation. When compared to subjects with normal QTc, subjects with prolonged QTc had higher mean tricuspid regurgitant jet velocity (2.51 +/- 0.27 m/sec vs. 2.33 +/- 0.26 m/sec, P = 0.010) as well as higher mean lactate dehydrogenase (433 +/- 142 IU/L vs. 343 +/- 142 IU/L, P = 0.000) and aspartate aminotransferase (48 +/- 20 IU/L vs. 39 +/- 15 IU/L, P = 0.026). A larger proportion of subjects with prolonged QTc also had a history of recurrent acute chest syndrome (66% vs. 38%, P = 0.038).
CONCLUSIONS: We conclude that QTc prolongation is a frequent finding in SCD not associated with LVH. Elevated pulmonary pressures, hemolysis and acute chest syndrome may represent risk factors for prolonged QTc in this population. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229972     DOI: 10.1002/pbc.21973

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

1.  A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload.

Authors:  Hugh Young Rienhoff; Vip Viprakasit; Lay Tay; Paul Harmatz; Elliott Vichinsky; Deborah Chirnomas; Janet L Kwiatkowski; Amy Tapper; William Kramer; John B Porter; Ellis J Neufeld
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

Review 2.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

3.  Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.

Authors:  Victor R Gordeuk; Caterina P Minniti; Mehdi Nouraie; Andrew D Campbell; Sohail R Rana; Lori Luchtman-Jones; Craig Sable; Niti Dham; Gregory Ensing; Josef T Prchal; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro
Journal:  Haematologica       Date:  2010-09-30       Impact factor: 9.941

4.  IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.

Authors:  Akash Gupta; Yu-Dong Fei; Tae Yun Kim; An Xie; Ken Batai; Ian Greener; Haiyang Tang; Sultan Ciftci-Yilmaz; Elizabeth Juneman; Julia H Indik; Guanbin Shi; Jared Christensen; Geetanjali Gupta; Cheryl Hillery; Mayank M Kansal; Devang S Parikh; Tong Zhou; Jason X-J Yuan; Yogendra Kanthi; Peter Bronk; Gideon Koren; Rick Kittles; Julio D Duarte; Joe G N Garcia; Roberto F Machado; Samuel C Dudley; Bum-Rak Choi; Ankit A Desai
Journal:  Blood       Date:  2021-03-04       Impact factor: 25.476

Review 5.  Mechanisms linking red blood cell disorders and cardiovascular diseases.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 6.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

Review 7.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

8.  Cardiac autonomic dysfunction in sickle cell anaemia and its correlation with QT parameters.

Authors:  Philip Manma Kolo; Emmanuel Olatunde Sanya; Timothy O Olanrewaju; Ademola E Fawibe; Ayodele Soladoye
Journal:  Niger Med J       Date:  2013-11

9.  Electrocardiographic abnormalities and dyslipidaemic syndrome in children with sickle cell anaemia.

Authors:  Samuel Ademola Adegoke; John Akintunde Okeniyi; Adeseye Abiodun Akintunde
Journal:  Cardiovasc J Afr       Date:  2015-08-08       Impact factor: 1.167

10.  Does Anemia Cause QT Prolongation in Patients with Hematologic Disorders?

Authors:  Yu-Dong Fei; Yi-Gang Li; William Surkis; Li Zhang
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.